Fresh analysis suggests that individuals who stop using popular slimming jabs like Wegovy and Mounjaro may regain shed pounds far faster than those who halt conventional lifestyle plans.
Published data in a major medical journal shows that while overweight people often shed substantial amounts of their body weight while on the medication, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"People using such drugs should be aware of the danger of rapid rebound weight gain when the medication ends," cautioned expert Dr. Susan Jebb.
This pace of recovery suggests a return to starting mass within about one and a half years.
Weighing Approaches
The research, which looked at dozens of trials involving thousands of patients, contrasted the effects of the injectable medications with older methods.
The team emphasize that individuals who lose weight through lifestyle changes alone typically see a slower weight regain—around 100 grams monthly—post-intervention.
Understanding the Quick Rebound
Experts propose the way of the jabs explains the heightened rebound.
The injections copy a natural hormone called glucagon-like peptide-1, which moderates hunger.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous GLP-1, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this medication results in appetite is uncontrolled, making overeating far more likely."
An Ongoing Disease?
The NHS recommend the injections for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, considering the significant potential of weight regain, the treatment should be considered long-term.
This perspective is echoed by pharmaceutical companies, who say that the findings "highlight the persistent character of obesity," akin to managing diseases like diabetes.
User Testimonies
Users who have stopped the jabs describe a sudden resurgence of cravings.
"It felt as if something flipping and you become starving," recalled a patient.
This difficulty is compounded if patients have not established sustainable dietary or behavioural modifications during treatment.
Growing Interest
Survey data show that a significant number of adults in the UK have tried these injections in the past year, with interest remaining high.
- Use is greater among females compared to males.
- The middle-aged age group shows the highest level of interest.
- Many access the medications through private prescriptions rather than public health services.
In conclusion, clinicians caution that while the jabs are potent agents for shedding pounds, they are not a standalone solution and lasting health benefits relies on ongoing behavioural changes.
